drugset / Trial / NCT05974033
IntraCranial Angiography-derived Fraction Flow-guided Percutaneous Transluminal Angioplasty and Stenting Versus Medical Therapy (ICAS-MT)
RandomizedParallel-groupSingle-blindTreatment
Summary
A multicenter, open-label, blinded-endpoint, prospective, randomized controlled clinical trial with an "all comers" design.
Timeline
- Start
- 2023-08
- Primary completion
- 2025-12
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Aspirin | Small molecule | 100 mg | — |
| Background | Clopidogrel | Small molecule | 75 mg | — |